Glucagon-like peptide-2 and its therapeutic use
US5834428A · kind A · utility
85Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 28, 1996 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | Jun 28, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/605
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon-like peptide 2, a product of glucagon gene expression, and analogs of glucagon-like peptide 2, have been identified as gastrointestinal tissue growth factors. Their effects on the growth of small bowel and pancreatic islets are described. Their formulation as a pharmaceutical, and their therapeutic use in treating disorders of the bowel, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.